NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update. "We...
Hence then, the article about brainstorm cell therapeutics announces second quarter 2026 financial results and provides corporate update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update )
Also on site :
- Clarks’ ‘Comfortable’ Loafers Have Shoppers Walking ‘All Day With No Fatigue,’ and They’re on Sale for $60
- We Asked 3 Disney Travel Experts for the Best Multigenerational Family Vacation Upgrade—They All Said the Same Thing
- Ted Lasso's Jason Sudeikis And Brett Goldstein Team With Sesame Street's Elmo And Oscar For Daily Affirmations — Watch Or Scram!